• Bausch
  • Recently, one particular product, ReNu with MoistureLoc brand of soft contact lens solutions made headlines regarding a report from the United States Centers for Disease Control and Prevention suggesting an increased incidence of a specific type of fungal keratitis (Fusarium keratitis) in people using Bausch & Lomb products. (wikipedia.org)
  • concentration
  • The basic contact lens solution comprises an effective concentration of BDT (preferably 1 to 100 parts per million), with naturally occurring plant products possessing activities complementary to BDT, in an isotonic diluent buffered with a physiologically acceptable buffer to a physiologically natural range. (google.co.uk)
  • 1. A contact lens solution containing a microbicidal concentration of Benzyldimethyl {2-[2-(p-1,1,3,3-tetramethylbutylphenoxy) ethoxy]ethyl} ammonium chloride. (google.co.uk)
  • 2. The contact lens solution of claim 1, wherein the concentration of Benzyldimethyl {2-[2-(p-1,1,3,3-tetramethylbutylphenoxy) ethoxy]ethyl} ammonium chloride is between 1 and 100 parts per million. (google.co.uk)
  • In animal studies, using four times the therapeutic concentration of the ophthalmic solution Latanoprost, the size of the palpebral fissure can be increased. (wikipedia.org)
  • infections
  • It is usually taken four or more times a day for the treatment of infections by instilling the solution in the eye. (reference.com)
  • The safety and effectiveness of Ofloxacin Ophthalmic Solution in treating ophthalmologic infections due to the following organisms have not been established in adequate and well-controlled clinical trials. (drugs.com)
  • Ofloxacin Ophthalmic Solution has been shown to be active in vitro against most strains of these organisms but the clinical significance in ophthalmologic infections is unknown. (drugs.com)
  • A non-ointment form of ophthalmic solution is also available for eye infections. (wikipedia.org)
  • minimize
  • To minimize contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. (drugs.com)
  • treatment
  • Serum, urine and tear concentrations of ofloxacin were measured in 30 healthy women at various time points during a ten-day course of treatment with Ofloxacin Ophthalmic Solution. (drugs.com)
  • Treatment with Rescula solution can be continued in patients who develop noticeably increased iris pigmentation. (drugs.com)
  • Contact Lenses
  • Benzyldimethyl {2-[2-(p-1,1,3,3-tetramethylbutylphenoxy)ethoxy]ethyl} ammonium chloride (BDT) forms the basis of contact lens solutions that are unusually effective at reducing the number and wide variety of pathogenic microorganisms that may infect rigid gas permeable or soft contact lenses. (google.co.uk)
  • Contact lenses should be removed prior to application of solution and may be reinserted 15 minutes following its administration [see Patient Counseling Information (17.4) ]. (drugs.com)
  • irritation
  • Furthermore, it has been discovered that natural occurring compounds alone and in combination with chemical agents can be used in ophthalmic solutions such as contact lens solution to enhance and complement their anti-microbial, cleaning and wetting activity or to reduce irritation to the eye. (google.co.uk)
  • Pharmaceuticals
  • The solution is developed, marketed, and distributed by Kowa Pharmaceuticals, but the compound itself was discovered by D. Western Therapeutics Institute, a company who specializes in protein kinase inhibitory compounds. (wikipedia.org)
  • Senju, in turn, has granted the United States rights for the ophthalmic preparation to ISTA Pharmaceuticals. (wikipedia.org)
  • wide
  • The formation of synechiae may be prevented by the use of this solution and atropine or other cycloplegics to produce wide dilation of the pupil. (drugs.com)
  • patients
  • The pigmentation is expected to increase as long as unoprostone isopropyl is administered, but has been reported to be reversible upon discontinuation of unoprostone isopropyl ophthalmic solution in most patients. (drugs.com)